Skip to main content
Fig. 3 | Surgical Case Reports

Fig. 3

From: A 5-year recurrence-free survivor with over ten colorectal liver metastases undergoing FOLFOX plus bevacizumab followed by two-stage hepatectomy

Fig. 3

Macroscopic and histological findings of the resected specimen. The fresh resected specimen on the 1st stage (a) and 2nd stage (b) hepatectomy showed several whitish tumors with a sufficient surgical margin behind the normal liver. Almost all parts of the bilateral CRLM showed complete necrosis (c, d) (H&E staining, objective; ×4, ×20); however, viable cells were detected only on marginal parts of the 2nd resected liver metastases (e). (H&E staining, objective; ×20)

Back to article page